Eric Wagner

We are excited to announce that TAC will be attending the Festival of Biologics in Basel from the 10th to the 12th of October. This is a new conference for us and looks fantastic covering all aspects from discovery through to final manufacture.

TAC recently completed a feasibility study on the “Selection and characterisation of anti-peptide synthetic antibodies for comparison with conventional reagents”, funded by IBioIC. Read all about it here

TAC was invited to give a talk on novel antibody production at the most recent ELRIG conference. Dr Jack Bryson presented “Production of Monoclonal Antibodies using a Phage-Display scFv Library: a Faster, More Flexible, and More Secure Complement to Hybridoma”. This generated a lot of discussion with some very interesting proposals for projects utilising this

The Antibody Company, TAC, has been recognised for high standards of excellence with silver accreditation from North Lanarkshire Council’s Employer Charter. The charter is based around four commitments by employers: to pay all staff at minimum the Real Living Wage; employ North Lanarkshire residents; use local businesses in the supply chain where possible; and ensure fair work practices

I’m excited to be starting my second MRes project at TAC. Under the supervision of both Eric Wagner and Mark Williams I will be carrying out antigen affinity purification to produce a pool of polyclonal antibodies against an expressed cell surface receptor on multiple myeloma cells, the cell culture of primary human myeloma cell lines

Glen Watt recently finished the first of two MRes projects at TAC. This was a challenging ‘high risk’ project and although we did not achieve everything we set out to Glen performed the work with a great deal of diligence and care. We are all very impressed with his work. Here is how it went

Another year, another quality audit. This one was a bit different from the last few. An actual onsite audit with real live people on site. No pressure! As useful as zoom/teams have been over the last couple of years (and will continue to be) there is no substitute for face to face meetings to really

TAC is looking for an Antibody Development Scientist. Company Overview  The Antibody Company, TAC, is a contract manufacturing organisation whose core specialisation is in the production of antibody from hybridoma and recombinant cell lines. TAC excels in working closely with clients to effectively partner with them to deliver their projects. As such, we work on

Early in January Glen Watt started a 3 month MRes project placement at TAC. He is already doing a fantastic job, learning lots and fitting in well. Here in his own words are his thoughts… “I am now in my 4th week of my Mres project placement The Antibody Company Ltd . Under the guidance of both Eric

One of our main core values is quality. Quality of the work that we perform. Quality of material that we provide to our clients. Each year we are externally audited to ensure that our quality system is performing and we are delighted that, once again, we have achieved full accreditation. Full credit goes to the